Roxiron-150 – Roxithromycin Tablets

1. Product Introduction

Roxiron-150 contains roxithromycin BP 150 mg per film-coated tablet. Roxithromycin is a semi-synthetic macrolide antibiotic that inhibits bacterial protein synthesis. It is used for susceptible bacterial infections where approved and prescribed by a clinician. Healthy Life Pharma Pvt. Ltd. and Healthy Inc are identified as manufacturing and export contacts in the supplied product brief; confirm actual manufacturing authorization and supply arrangements before publication.

2. Product Specifications

3. Manufacturing Technology

For roxithromycin film-coated tablets, formulation development may evaluate blend uniformity, granulation or compression performance, disintegration, dissolution, stability and taste-masking film coatings. Manufacturing process details, specialized equipment, packaging configurations and production site should be verified against approved technical documents rather than assumed.

4. Quality Assurance

Relevant controls include identity, assay, content uniformity, dissolution, related substances, microbiological quality where applicable and stability testing under the approved pharmacopoeial or registration specification. Numerical assay or dissolution limits must follow the actual approved method; no unverified acceptance limits are claimed here.

5. Therapeutic Uses

Roxithromycin is used for certain susceptible bacterial infections, which may include respiratory tract, ear/nose/throat, skin and soft-tissue infections, depending on local product approvals and bacterial susceptibility. It does not treat viral illnesses such as colds or influenza. Use should reflect local antimicrobial-resistance guidance and clinician assessment.

Mechanism: binds to the bacterial 50S ribosomal subunit and inhibits protein synthesis.

6. Export and Regulatory Support

For wholesale, institutional and export enquiries, request current manufacturing licenses, product registration status, batch certificates of analysis, stability information, applicable GMP evidence and country-specific dossiers from the supplier. CTD/ACTD, COPP, FSC, shipment terms and country registrations are subject to confirmation.

7. Frequently Asked Questions

8. Dosage and Administration

Prescription-only antibiotic. Dose, frequency and duration depend on the infection, age, organ function, susceptibility and locally approved prescribing information. Take exactly as directed and do not self-medicate or share antibiotics. Do not use a general dosage schedule in place of the approved 150 mg product label.

9. Side Effects and Precautions

Potential adverse effects include nausea, abdominal discomfort, diarrhea, headache, rash and liver enzyme changes. Seek urgent care for severe allergic reaction, severe or persistent diarrhea, jaundice, palpitations or fainting. Macrolides may prolong the QT interval; review heart-rhythm history and interacting medicines. Clinicians should review possible interactions, including ergot derivatives and medicines associated with QT prolongation, and exercise caution in hepatic disease.

10. Storage Instructions

Keep in original packaging, protected from moisture and excessive heat, and out of reach of children. Follow the temperature and shelf-life instructions printed on the approved product label; no unverified specific temperature or 36-month shelf life is asserted.